Nutex Health (Nutex Health) Risk Assessment

View and export this data going back to 2022. Start your Free Trial

What is Nutex Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Nutex Health is: No Data: Cannot be evaluated.

Competitive Comparison of Nutex Health's Risk Assessment

For the Health Information Services subindustry, Nutex Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nutex Health's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Nutex Health's Risk Assessment falls into.

Nutex Health (NAS:NUTX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Nutex Health Risk Assessment Related Terms

Thank you for viewing the detailed overview of Nutex Health's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Nutex Health (Nutex Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nutex Health Inc (NAS:NUTX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

6030 S. Rice Ave, Suite C, Houston, TX, USA, 77081

Website

https://www.nutexhealth.com

Nutex Health Inc is healthcare services and operations company with 19 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Executives

Thomas T. Vo	director, officer: Chairman, CEO	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Joshua Detillio	officer: Chief Operating Officer	6030 S. RICE AVENUE, SUITE C, HOUSTON TX 77081
Jon Christian Bates	officer: Chief Financial Officer	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Mitchell Creem	director	700 NORTH BRAND BLVD., SUITE 450, GLENDALE CA 91203
Pamela W. Montgomery	officer: Chief Legal Off. & Secretary	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Michael Lee Reed	director	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Cheryl Yvonne Grenas	director	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
John J Waters	director	2165 TECHNOLOGY DRIVE, SCHENECTADY NY 12308
Danniel Stites	director	3050 S. DOBSON ROAD, CHANDLER AZ 85248
Premier Macy Management Holdings, Llc	10 percent owner	2819 CYPRESS DRIVE, TEXARKANA TX 75503
Michael Bowen	officer: Chief Financial Officer	501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701
Warren Hosseinion	director	C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Lawrence Schimmel	officer: Chief Medical Information Off	5193 SW 75TH STREET, MIAMI FL 33143
Frederick Sternberg	officer: President of subsidiary	10772 SANDY RUN RD, JUPTIER FL 33478
Micro Hospital Holding Llc	10 percent owner	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081